Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer

At the beginning of the COVID-19 pandemic, patients with primary and secondary immune disorders—including patients suffering from cancer—were generally regarded as a high-risk population in terms of COVID-19 disease severity and mortality. By now, scientific evidence indicates that there is substant...

Descripción completa

Detalles Bibliográficos
Autores principales: Solimando, Antonio G., Bittrich, Max, Shahini, Endrit, Albanese, Federica, Fritz, Georg, Krebs, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218128/
https://www.ncbi.nlm.nih.gov/pubmed/37240091
http://dx.doi.org/10.3390/ijms24108746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218128/
https://www.ncbi.nlm.nih.gov/pubmed/37240091
http://dx.doi.org/10.3390/ijms24108746

Ejemplares similares